The World Nicotine Congress (WNC) brought together global leaders from science, industry,...
U.S. Tobacco & Nicotine Regulatory Update - Spring 2026
Since December, FDA actions have begun to define a more targeted and consequential regulatory landscape. This evolving posture reflects a dual track: improving transparency and efficiency in product review, while reinforcing expectations around...
Results - 113 Blogs
A key focus in discussions around the safety of nicotine pouches relates to child-resistant...
On February 10, 2026, FDA’s Center for Tobacco Productsconvened a full-day Small Manufacturer ENDS...
Last week’s announcement from FDA regarding the authorization of on! PLUS was very encouraging....
For much of the past decade, the US nicotine and ENDS marketplace has operated in a state of...
In 2025, Sweden achieved something virtually unheard of elsewhere: it became and may soon be...
The inaugural PouchEx 2025 conference, dedicated exclusively to nicotine pouches, was a niche event...
The 2025 Food and Drug Law Institute (FDLI) Tobacco and Nicotine Conference delivered something the...
When FDA deployed the “fatal flaw” concept during ENDS PMTA reviews, it was seen by many as a...
If you have a specific question for one of our scientific or regulatory experts, get in touch with a member of our team today.
